BNP Paribas Financial Markets’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $183K | Buy |
11,845
+11,169
| +1,652% | +$173K | ﹤0.01% | 2993 |
|
|
2025
Q1 | $10.1K | Sell |
676
-500,001
| -100% | -$7.43M | ﹤0.01% | 3880 |
|
|
2024
Q4 | $6.63M | Buy |
500,677
+497,457
| +15,449% | +$6.59M | ﹤0.01% | 1106 |
|
|
2024
Q3 | $45.8K | Buy |
3,220
+2,596
| +416% | +$36.9K | ﹤0.01% | 2903 |
|
|
2024
Q2 | $8.08K | Sell |
624
-88
| -12% | -$1.14K | ﹤0.01% | 3063 |
|
|
2024
Q1 | $9.89K | Hold |
712
| – | – | ﹤0.01% | 3019 |
|
|
2023
Q4 | $10.2K | Sell |
712
-83
| -10% | -$1.18K | ﹤0.01% | 2997 |
|
|
2023
Q3 | $12.3K | Sell |
795
-1,986
| -71% | -$30.7K | ﹤0.01% | 2927 |
|
|
2023
Q2 | $43.7K | Buy |
2,781
+759
| +38% | +$11.9K | ﹤0.01% | 2883 |
|
|
2023
Q1 | $33.3K | Buy |
2,022
+1,062
| +111% | +$17.5K | ﹤0.01% | 2846 |
|
|
2022
Q4 | $15K | Hold |
960
| – | – | ﹤0.01% | 2914 |
|
|
2022
Q3 | $12.5K | Sell |
960
-2,804
| -74% | -$36.4K | ﹤0.01% | 3444 |
|
|
2022
Q2 | $52.8K | Sell |
3,764
-90,613
| -96% | -$1.27M | ﹤0.01% | 2909 |
|
|
2022
Q1 | $1.35M | Sell |
94,377
-178,625
| -65% | -$2.56M | ﹤0.01% | 1628 |
|
|
2021
Q4 | $3.72M | Buy |
273,002
+229,978
| +535% | +$3.13M | 0.01% | 1113 |
|
|
2021
Q3 | $705K | Buy |
43,024
+888
| +2% | +$14.5K | ﹤0.01% | 2040 |
|
|
2021
Q2 | $709K | Sell |
42,136
-215,754
| -84% | -$3.63M | ﹤0.01% | 1832 |
|
|
2021
Q1 | $4.71M | Sell |
257,890
-75,000
| -23% | -$1.37M | 0.01% | 892 |
|
|
2020
Q4 | $6.06M | Buy |
332,890
+21,678
| +7% | +$395K | 0.01% | 696 |
|
|
2020
Q3 | $5.55M | Sell |
311,212
-30,183
| -9% | -$538K | 0.01% | 739 |
|
|
2020
Q2 | $6.12M | Buy |
341,395
+8,539
| +3% | +$153K | 0.01% | 679 |
|
|
2020
Q1 | $5.05M | Buy |
332,856
+13,837
| +4% | +$210K | 0.01% | 695 |
|
|
2019
Q4 | $6.29M | Buy |
319,019
+5,064
| +2% | +$99.9K | 0.01% | 726 |
|
|
2019
Q3 | $5.4M | Sell |
313,955
-6,730
| -2% | -$116K | 0.01% | 700 |
|
|
2019
Q2 | $5.68M | Buy |
+320,685
| New | +$5.68M | 0.01% | 653 |
|